About UR-REGENESIS
Networking between members and organisations
Experts in regenerative medicine and people interested in this
project may work for large organisations that pursue networking
between organisations of similar interests. Collaborative
agreements for complementary work of partner organisations will
be highly encouraged.
Professionals who were invited to participate in this project
currently work for:
1. large universities (e.g. Cambridge University, Imperial College
London, Harvard Medical School, King's College London,
Karolinska Institutet, McGill University, University Hospital Lund,
The University of Alberta, Toronto, Pittsburgh, Pennsylvania,
Nebraska, Bristol, Oxford, Dundee, Bonn, Tokyo, Tokushima,
Hiroshima University, Nippon Medical School, Baylor College of
Medicine, etc.),
2. research organizations (e.g. Pennington Biomedical Research
Centre, Howard Hughes Medical Institute at the Salk Institute,
McGowan Institute for Regenerative Medicine, Peter MacCallum
Cancer Centre, John F. Kennedy Institute, Internationales
Forschungsinstitut für Paraplegiologie, International Brain
Research Organisation, European Tissue Engineering
Association, International society for Cellular Therapy, Beijing
Institute of Radiation Medicine, Institut System Technik and
Innovations Forschung, Canadian Institute of Health Research,
etc.),
3. private clinics, local and national hospitals (e.g. Green Lane
Hospital),
4. national organisations including research councils (e.g. the
BBSRC, the MRC),
5. charities (Wellcome Trust, Royal Society for Medicine,
International Spinal Research Trust, Julia Polak Research Trust,
Christopher and Dana Reeves Foundation, ),
6. the National Blood Service, the National Health Service or
NHS, and other powerful national organisations (e.g. the Press
Office, the Metropolitan Police, the Royal Family, the Ministry of
Defence),
7. companies or institutions already involved in applied specific
regenerative medicine (e.g. NovaThera, Cognate Therapeutics
Inc., CellTran, CereStem, Adjuvantix Limited, Plasso Limited,
Photopharmica, Organogenesis Inc., Co.Don AG, Genzyme
Biosurgery, Skinethic Laboratories, Intercytex, CellChip,
ReNeuron Corporation, Emofree, Luncheon, MacroPore
Biosurgery Inc., Sysmex America, etc.),
8. international non-governmental organisations (NGO) including
pharmaceutical companies (GlaxoSmithKline, Pfizer, Novartis,
Astra-Zeneca, Roche, Schering),
9. companies of the food industry involved in fomenting the
intake of natural organic regenerative aliments (Nestle, Danone)
10. companies producing physiotherapeutical clothing for the
health and sport industries (Nike),
11. patenting offices (e.g. The European Patenting Office),
12. international regulatory organisations (e.g. the European
Commission, Office of the United Nations High Commissioner of
Human Rights -OHCHR-, the World Health Organisation -WHO-).
Massive media coverage will help committed organisations to
advertise their input in this global initiative. Our aim is to
emphasise their worldwide leadership in promoting the unlimited
potential of regenerative medicine.
project may work for large organisations that pursue networking
between organisations of similar interests. Collaborative
agreements for complementary work of partner organisations will
be highly encouraged.
Professionals who were invited to participate in this project
currently work for:
1. large universities (e.g. Cambridge University, Imperial College
London, Harvard Medical School, King's College London,
Karolinska Institutet, McGill University, University Hospital Lund,
The University of Alberta, Toronto, Pittsburgh, Pennsylvania,
Nebraska, Bristol, Oxford, Dundee, Bonn, Tokyo, Tokushima,
Hiroshima University, Nippon Medical School, Baylor College of
Medicine, etc.),
2. research organizations (e.g. Pennington Biomedical Research
Centre, Howard Hughes Medical Institute at the Salk Institute,
McGowan Institute for Regenerative Medicine, Peter MacCallum
Cancer Centre, John F. Kennedy Institute, Internationales
Forschungsinstitut für Paraplegiologie, International Brain
Research Organisation, European Tissue Engineering
Association, International society for Cellular Therapy, Beijing
Institute of Radiation Medicine, Institut System Technik and
Innovations Forschung, Canadian Institute of Health Research,
etc.),
3. private clinics, local and national hospitals (e.g. Green Lane
Hospital),
4. national organisations including research councils (e.g. the
BBSRC, the MRC),
5. charities (Wellcome Trust, Royal Society for Medicine,
International Spinal Research Trust, Julia Polak Research Trust,
Christopher and Dana Reeves Foundation, ),
6. the National Blood Service, the National Health Service or
NHS, and other powerful national organisations (e.g. the Press
Office, the Metropolitan Police, the Royal Family, the Ministry of
Defence),
7. companies or institutions already involved in applied specific
regenerative medicine (e.g. NovaThera, Cognate Therapeutics
Inc., CellTran, CereStem, Adjuvantix Limited, Plasso Limited,
Photopharmica, Organogenesis Inc., Co.Don AG, Genzyme
Biosurgery, Skinethic Laboratories, Intercytex, CellChip,
ReNeuron Corporation, Emofree, Luncheon, MacroPore
Biosurgery Inc., Sysmex America, etc.),
8. international non-governmental organisations (NGO) including
pharmaceutical companies (GlaxoSmithKline, Pfizer, Novartis,
Astra-Zeneca, Roche, Schering),
9. companies of the food industry involved in fomenting the
intake of natural organic regenerative aliments (Nestle, Danone)
10. companies producing physiotherapeutical clothing for the
health and sport industries (Nike),
11. patenting offices (e.g. The European Patenting Office),
12. international regulatory organisations (e.g. the European
Commission, Office of the United Nations High Commissioner of
Human Rights -OHCHR-, the World Health Organisation -WHO-).
Massive media coverage will help committed organisations to
advertise their input in this global initiative. Our aim is to
emphasise their worldwide leadership in promoting the unlimited
potential of regenerative medicine.
Maria Cristina Ovejero-Boglione
Dear losing & regenerating antlers
Stem cells differentiated into neurons?
 |
| |
 |
| |
 |
| |
 |